MTOR and acute graft versus host disease: The responses of AKT (Thr308), mTOR (Ser2448) and STAT3 (Ser727) were generally stronger for patients with previous acute GVHD; i.e., usually highly significant responses for all three phosphosites and all three cell subsets.